Thyroid Cancer Clinical Trial
Official title:
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
The purpose of the investigators study is to retrospectively evaluate the predictors of malignant thyroid nodules and established an useful scoring system based on sonographic findings and demographic data.
Background:
Some sonographic appearance can help in selection of the correct thyroid nodes to aspirate
with US(ultrasound)-guided FNA(fine needle aspiration) biopsy. Findings suggestive for
malignant thyroid cancer include micro-calcification, blurred margins, intra-nodular
vascular pattern, marked hypoechogenicity or taller-than-wide shape.1-3 However, no single
criteria can perfectly predict malignant thyroid nodules. Applied multiple US criteria for
the differentiation of thyroid nodule has an overall accuracy ranging from 59.5 to 73.4%.3
Objective:
The purpose of our study is to retrospectively evaluate the predictors of malignant thyroid
nodules and established an useful scoring system based on sonographic findings and
demographic data.
Material and methods:
This study will be conducted according to the principle of Helsinki declaration and the
guidelines of the institutional ethical committee. We want to retrospectively review the
medical records of 479 nodules which underwent head and neck ultrasound(US) examination and
US-FNA cytology from 2007 July to 2010 Dec at Department of Otolaryngology, Far Eastern
Memorial Hospital, Taipei, Taiwan. No patient included in this series had a previous
diagnosis of thyroid malignancy.
Equipment for US studies consisted of a color Doppler US unit (Philips HDI 5000, Bothell,
WA) and a 5-12 MHz broadband linear array transducer. Nodules were measured with AP and
transverse (T) diameters in transverse section. Settings of power Doppler sonography were
set for high sensitivity with a low wall filter to allow detection of vessels with low blood
flow. The color gain was increased until background noise appeared and then reduced until
the noise was suppressed, thus ensuring maximum sensitivity according to Bude and Rubin's
description.4 The vascularity types are classified as avascular, peripheral and intra-nodule
types1,5. The echo structure (predominantly solid or cyst), internal echo (homogeneous or
heterogenicity), echogenicity (hyperechoic, isoechoic, hypoechoic), presented
micro-calcification, and characteristics of nodule margin (well-defined or ill defined) were
assessed. Thyroid incidentalomas are thyroid nodules without clinically apparent tumor but
are incidentally found by US.
US-FNA was carried out with the array probe guiding the placement of a 22-gauge fine needle
after informed consent was obtained. The final diagnosis of a lesion as benign (n=449) or
malignancy (n=30) was confirmed by FNA biopsy. The relationship between demographic data,
sonographic features and final diagnosis, i.e. benign or malignant disease was analyzed in
all 479 nodules. In univariate analysis, Chi-square test or Fisher exact test was performed
to compare for categorical variables, and student t- test for continuous variables. A
stepwise multivariate logistic regression analysis was applied to identify significant
independent variables for prophesying malignant nodal disease. The level of significance was
set at p < 0.05. The predictive formula was based on multivariate logistic regression
analysis and programmed into a real-time, computerized sonographic reporting system.
Hosmer-Lemeshow test6 was carried out to verify the significance of the prediction model.
The association between prediction score and malignant nodal disease was analyzed using the
receiver operating characteristic (ROC) curve. An optimal cutoff point was determined at the
point of greatest "sensitivity" with the corresponding smallest "1-specificity".7 The
c-value as a measure for the area under the curve represented the diagnostic accuracy of the
model.8 All statistical analyses were accomplished using SAS software, version 9.1 (SAS
Institute, Inc, Cary, North Carolina).
Expected Results: A simple and practical sonographic scoring system would be built to
provide the physician prompt and reliable probability guidance for FNA cytology while
managing thyroid nodule.
References:
1. Cappelli C, Castellano M, Pirola Iet al. The predictive value of ultrasound findings in
the management of thyroid nodules. Qjm 2007; 100:29.
2. Kim E, Park C, Chung Wet al. New sonographic criteria for recommending fine-needle
aspiration biopsy of nonpalpable solid nodules of the thyroid. American Journal of
Roentgenology 2002; 178:687.
3. Moon W, Jung S, Lee Jet al. Benign and Malignant Thyroid Nodules: US
Differentiation—Multicenter Retrospective Study1. Radiology 2008; 247:762.
4. Bude R, Rubin J. Power Doppler sonography. Radiology 1996; 200:21.
5. Rago T, Vitti P, Chiovato Let al. Role of conventional ultrasonography and color
flow-doppler sonography in predicting malignancy in'cold'thyroid nodules. European
Journal of Endocrinology 1998; 138:41.
6. Lemeshow S, Hosmer Jr D. A review of goodness of fit statistics for use in the
development of logistic regression models. American Journal of Epidemiology 1982;
115:92.
7. Akobeng A. Understanding diagnostic tests 3: receiver operating characteristic curves.
Acta Paediatrica 2007; 96:644-647.
8. McNeil B, Hanley J. The meaning and use of the area under a receiver operating
characteristic (ROC) curve. Radiology 1982; 143:29-36.
;
Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
Withdrawn |
NCT04224792 -
Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors
|
N/A | |
Completed |
NCT01728623 -
A Study of E7080 in Subjects With Advanced Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT02911155 -
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Not yet recruiting |
NCT03978351 -
The Role of Midkine in Diagnosis of Thyroid Cancer
|
||
Completed |
NCT02658513 -
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
|
||
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Withdrawn |
NCT01994200 -
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT01403324 -
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
|
N/A | |
Completed |
NCT00970359 -
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
|
N/A | |
Completed |
NCT00439478 -
Dental Safety Profile of High-Dose Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT00223158 -
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
|
N/A | |
Active, not recruiting |
NCT04544111 -
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
|
Phase 2 | |
Completed |
NCT04876287 -
Salivary dysfuncTion After Radioiodine Treatment
|
||
Recruiting |
NCT06073223 -
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
|
N/A | |
Recruiting |
NCT06037174 -
Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery
|
||
Recruiting |
NCT04952493 -
Anlotinib or Penpulimab in Combination With RAI for DTC
|
Phase 2 |